Vaxart, Inc.
For the period ended May 19, 2026. Filed May 19, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
May 19, 2026 · Filed May 19, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · A Clear Focus on Delivering for Shareholders
A Clear Focus on Delivering for Shareholders
Our Board and management team are fully focused on the priorities that will drive value for shareholders. We strongly believe in the future of our Company and the ability of our oral vaccine programs to improve health outcomes and create shareholder value. With your support, we can capture the significant opportunities ahead.
Thank you for your continued support of Vaxart.
Sincerely,
The Vaxart Board of Directors
Shareholders are encouraged to visit Vote.Vaxart.com for additional information on Vaxart’s value creation strategy, its highly qualified Board of Directors and its Annual Meeting of Stockholders.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.